Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Egg	O
/	O
Morphine	O
Sulfate	O
/	O
Propofol	O
Analogues	O
Attending:	O
___.	O
Chief	O
Complaint:	O
dyspnea	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
1.	O
Cardiac	O
catheterization	O
___	O
2.	O
Cardiac	O
stenting	O
of	O
left	O
main	O
coronary	O
artery	O
and	O
right	O
coronary	O
artery	O
___	O
3.	O
Tunneled	O
hemodialysis	O
line	O
placement	O
___	O
History	O
of	O
Present	O
Illness:	O
Mrs.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
with	O
CAD	O
(S/p	O
BMS	O
to	O
mid	O
LAD	O
in	O
___,	O
sCHF	O
(EF	O
40%),	O
PVD	O
s/p	O
R	O
axillobifemoral	O
bypass	O
with	O
graft	O
which	O
the	O
fem-fem	O
is	O
now	O
occluded,	O
carotid	O
endarterectomy	O
x	O
2	O
on	O
the	O
left	O
last	O
in	O
___,	O
s/p	O
SMA	O
PCI,	O
COPD	O
(on	O
2L	O
NC),	O
PEs	O
on	O
coumadin	O
who	O
presents	O
intubated/sedated	O
from	O
___	O
in	O
setting	O
of	O
acute	O
pulmonary	O
edema,	O
respiratory	O
failure,	O
oliguric	O
___,	O
and	O
critical	O
left	O
main	O
disease.	O
.	O
Patient	O
was	O
transferred	O
from	O
___.	O
She	O
had	O
recently	O
been	O
discharged	O
after	O
treatment	O
of	O
pneumonia	B-Lower_respiratory_tract_infection
(unknown	O
antibiotic	O
course),	O
and	O
while	O
at	O
home	O
in	O
days	O
after	O
discharge,	O
developed	O
progressive	O
dyspnea	O
and	O
possible	O
fever.	O
She	O
denied	O
sputum	O
production	O
or	O
cough.	O
BNP	O
on	O
admission	O
was	O
1000,	O
up	O
from	O
600	O
during	O
previous	O
admission	O
for	O
pneumonia.	B-Lower_respiratory_tract_infection
She	O
was	O
started	O
on	O
Zpack,	O
ceftriaxone,	O
and	O
levofloxacin	O
for	O
pneumonia/COPD	I-Lower_respiratory_tract_infection
exacerbation,	B-Lower_respiratory_tract_infection
and	O
given	O
IV	O
lasix	O
20mg	O
tid	O
for	O
pulmonary	O
edema.	O
She	O
does	O
not	O
take	O
lasix	O
as	O
an	O
outpatient.	O
She	O
was	O
noted	O
to	O
have	O
a	O
Cr	O
of	O
1.4	O
on	O
admission,	O
which	O
rose	O
to	O
4.8	O
with	O
diuresis.	O
Lasix	O
was	O
discontinued	O
and	O
renal	O
consult	O
was	O
obtained,	O
who	O
recommended	O
stopping	O
lasix,	O
giving	O
IVF	O
for	O
pre-renal	O
azotemia,	O
and	O
changing	O
levofloxacin	O
to	O
ampicillin.	O
She	O
was	O
also	O
found	O
to	O
have	O
an	O
enterococcus	O
UTI	B-Urinary_tract_infection
and	O
started	O
on	O
unasyn.	O
ID	O
and	O
heme/onc	O
consultations	O
were	O
obtained	O
for	O
leukocytosis	O
19	O
with	O
left	O
shift.	O
Both	O
agreed	O
that	O
leukocytosis	O
was	O
likely	O
reactive,	O
but	O
to	O
treat	O
pneumonia	B-Lower_respiratory_tract_infection
and	O
UTI,	B-Urinary_tract_infection
and	O
to	O
follow-up	O
with	O
outpatient	O
records.	O
Patient	O
does	O
have	O
chronic	O
leukocytosis	O
and	O
thrombocytosis	O
noted	O
during	O
prior	O
admission	O
to	O
BI	O
as	O
well.	O
Per	O
heme/onc	O
consultation	O
at	O
that	O
time,	O
pattern	O
appeared	O
less	O
likely	O
to	O
be	O
MDS,	O
more	O
likely	O
to	O
be	O
reactive,	O
possibly	O
related	O
to	O
iron	O
deficiency	O
as	O
well.	O
Patient	O
was	O
initiated	O
on	O
HD	O
4	O
days	O
prior	O
to	O
transfer,	O
received	O
third	O
run	O
of	O
HD	O
today,	O
during	O
which	O
she	O
developed	O
acute	O
left-sided	O
chest	O
pain,	O
___,	O
not	O
radiating.	O
She	O
developed	O
severe	O
respiratory	O
distress,	O
was	O
intubated,	O
had	O
then	O
noted	O
to	O
have	O
new	O
inferiorlateral	O
ST	O
depressions	O
on	O
her	O
EKG	O
(I	O
and	O
aVL	O
and	O
V6)	O
then	O
goes	O
to	O
cath	O
lab	O
where	O
they	O
find	O
90%	O
LM,	O
70%	O
RCA,	O
but	O
no	O
interventions	O
were	O
performed.	O
She	O
was	O
transferred	O
to	O
the	O
___	O
CCU	O
for	O
further	O
management.	O
.	O
Unable	O
to	O
obtain	O
ROS	O
as	O
patient	O
is	O
intubated.	O
Past	O
Medical	O
History:	O
CAD	O
s/p	O
PCI	O
to	O
LAD	O
(___)	O
CHF	O
L	O
CEA	O
R	O
axillobifemoral	O
bypass	O
with	O
graft	O
mult	O
foot/ankle	O
surgeries	O
HTN	O
COPD	O
on	O
home	O
O2	O
(2L	O
nightly,	O
occasionally	O
during	O
the	O
day)	O
s/p	O
nephrectomy	O
incarcerated	O
umbilical	O
hernia	O
s/p	O
repair	O
___	O
acute	O
cholecystitis	O
s/p	O
cholecystostomy	O
drainage	O
___	O
asthma	O
PE	O
x	O
2	O
on	O
coumadin	O
CKD	O
Ischemic	O
colitis,	O
chronic	O
s/p	O
celiac	O
and	O
SMA	O
stents	O
Bladder	O
cancer:	O
Recent	O
treatment	O
history	O
at	O
___,	O
she's	O
had	O
3	O
procedures	O
in	O
the	O
past	O
couple	O
years	O
including	O
chemical	O
bath	O
of	O
the	O
bladder.	O
Last	O
2	O
checks	O
were	O
clear.	O
Urologist	O
is	O
___	O
___	O
___.	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
MI	O
@	O
___,	O
mother	O
AD,	O
sister	O
DM2.	O
No	O
hx	O
of	O
DVTs,	O
PEs.	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death;	O
otherwise	O
non-contributory.	O
Physical	O
Exam:	O
PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION:	O
VS:	O
T___.4	O
BP=	O
111/59	O
HR=91	O
RR=20	O
O2	O
sat=	O
98(intubated)	O
___:	O
intubated,	O
sedated,	O
but	O
arousable	O
and	O
can	O
answer	O
yes/no	O
to	O
questions	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL.	O
CARDIAC:	O
RRR,	O
normal	O
S1,	O
S2.	O
No	O
m/r/g.	O
No	O
thrills,	O
lifts.	O
No	O
S3	O
or	O
S4.	O
LUNGS:	O
intubated,	O
anterior	O
lung	O
exam	O
revealed	O
no	O
crackles,	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Normoactive	O
bowel	O
sounds,	O
soft,	O
NTND.	O
EXTREMITIES:	O
cold,	O
clamy,	O
faintly	O
palpable	O
DP	O
and	O
___	O
pulses	O
b/l	O
NEURO:	O
sedated	O
but	O
arousable,	O
able	O
to	O
squeeze	O
with	O
both	O
hands	O
and	O
move	O
both	O
feet	O
to	O
command	O
.	O
PHYSICAL	O
EXAM	O
ON	O
DISCHARGE:	O
97.9	O
89	O
139/46	O
20	O
98%	O
on	O
2L	O
___:	O
awake,	O
in	O
NAD,	O
AOx2	B-Unspecified_cognitive_impairment
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL.	O
CARDIAC:	O
RRR,	O
normal	O
S1,	O
S2.	O
Grad	O
___	O
ejection	O
systolic	O
murmur,	O
loudest	O
in	O
RUSB.	O
No	O
thrills,	O
lifts.	O
No	O
S3	O
or	O
S4.	O
LUNGS:	O
anterior	O
lung	O
exam	O
revealed	O
some	O
crackles	O
in	O
bases,	O
but	O
no	O
wheezes	O
or	O
rhonchi.	O
ABDOMEN:	O
Normoactive	O
bowel	O
sounds,	O
soft,	O
NTND.	O
EXTREMITIES:	O
faintly	O
palpable	O
DP	O
and	O
___	O
pulses	O
b/l	O
NEURO:	O
Patient	O
AOX2,	B-Unspecified_cognitive_impairment
but	O
still	O
appears	O
very	O
weak.	O
No	O
gross	O
deficits	O
Pertinent	O
Results:	O
Labs	O
on	O
Admission:	O
___	O
10:00PM	O
BLOOD	O
WBC-37.7*#	O
RBC-4.37	O
Hgb-12.1	O
Hct-36.3	O
MCV-83	O
MCH-27.7#	O
MCHC-33.3	O
RDW-19.3*	O
Plt	O
___	O
___	O
10:00PM	O
BLOOD	O
Neuts-76*	O
Bands-6*	O
Lymphs-2*	O
Monos-6	O
Eos-2	O
Baso-0	O
___	O
Metas-7*	O
Myelos-1*	O
___	O
10:00PM	O
BLOOD	O
Hypochr-NORMAL	O
Anisocy-2+	O
Poiklo-2+	O
Macrocy-1+	O
Microcy-1+	O
Polychr-1+	O
Ovalocy-2+	O
Burr-OCCASIONAL	O
Tear	O
___	O
___	O
10:00PM	O
BLOOD	O
___	O
PTT-105.8*	O
___	O
___	O
10:00PM	O
BLOOD	O
Glucose-135*	O
UreaN-19	O
Creat-2.6*#	O
Na-142	O
K-5.0	O
Cl-102	O
HCO3-24	O
AnGap-21*	O
___	O
10:00PM	O
BLOOD	O
LD(LDH)-671*	O
CK(CPK)-235*	O
TotBili-0.5	O
___	O
10:00PM	O
BLOOD	O
Calcium-8.9	O
Phos-6.6*#	O
Mg-2.0	O
___	O
10:00PM	O
BLOOD	O
Hapto-305*	O
.	O
Cardiac	O
Enzymes:	O
___	O
10:00PM	O
BLOOD	O
CK-MB-24*	O
MB	O
Indx-10.2*	O
cTropnT-0.55*	O
___	O
02:04AM	O
BLOOD	O
CK-MB-23*	O
MB	O
Indx-9.6*	O
cTropnT-1.00*	O
___	O
04:16PM	O
BLOOD	O
CK-MB-11*	O
MB	O
Indx-5.2	O
cTropnT-1.18*	O
.	O
Lactates:	O
___	O
10:37PM	O
BLOOD	O
Lactate-2.7*	O
___	O
04:33PM	O
BLOOD	O
Lactate-1.0	O
.	O
TTE	O
___:	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
Left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal.	O
The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal.	O
LV	O
systolic	O
function	O
appears	O
moderately-to-severely	O
depressed	O
(ejection	O
fraction	O
30	O
percent)	O
secondary	O
to	O
akinesis	O
of	O
the	O
septum	O
and	O
hypokinesis	O
of	O
the	O
anterior	O
free	O
wall,	O
inferior	O
free	O
wall,	O
and	O
lateral	O
wall.	O
Contractile	O
function	O
of	O
the	O
posterior	O
wall	O
appears	O
preserved.	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
(?#).	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Mild	O
(1+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
impaired	O
relaxation.	O
The	O
tricuspid	O
regurgitation	O
jet	O
is	O
eccentric	O
and	O
may	O
be	O
underestimated.	O
There	O
is	O
mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.	O
.	O
Renal	O
Ultrasound	O
___:	O
IMPRESSION:	O
No	O
hydronephrosis.	O
No	O
change	O
from	O
a	O
CT	O
in	O
___.	O
.	O
CARDIAC	O
CATH	O
___	O
COMMENTS:	O
1.	O
Successful	O
PCI	O
of	O
the	O
___	O
with	O
a	O
3.0x15mm	O
Promus	O
DES,	O
post-dilated	O
to	O
4.0mm.	O
2.	O
Successful	O
PCI	O
to	O
the	O
RCA	O
with	O
a	O
3.0x23mm	O
Promus	O
DES,	O
post-dilated	O
to	O
3.5mm.	O
3.	O
Terumo	O
band	O
to	O
the	O
right	O
radial	O
artery.	O
4.	O
No	O
complications.	O
.	O
FINAL	O
DIAGNOSIS:	O
1.	O
Two	O
vessel	O
coronary	O
artery	O
disease.	O
2.	O
Successful	O
PCI	O
to	O
the	O
___	O
and	O
RCA	O
with	O
Promus	O
DES.	O
3.	O
Patient	O
to	O
remain	O
on	O
aspirin	O
and	O
clopidogrel	O
indefinitely,	O
without	O
interruption.	O
4.	O
No	O
complications.	O
.	O
CT	O
head	O
___	O
IMPRESSION:	O
1.	O
Left	O
occipital	O
lobe	O
loss	O
of	O
gray-white	O
differentiation	O
could	O
be	O
related	O
an	O
acute	O
on	O
chronic	O
infarct.	O
An	O
MR	O
may	O
be	O
obtained	O
for	O
further	O
evaluation.	O
2.	O
Left	O
maxillary	O
sinus	O
fluid.	O
.	O
MRI	O
head	O
___	O
IMPRESSION:	O
1.	O
Chronic	O
infarction	O
identified	O
in	O
the	O
left	O
parietooccipital	O
region	O
with	O
extensive	O
area	O
of	O
encephalomalacia,	O
associated	O
chronic	O
microvascular	O
ischemic	O
disease	O
is	O
present.	O
2.	O
Punctate	O
areas	O
of	O
restricted	O
diffusion	O
are	O
noted	O
in	O
the	O
subcortical	O
white	O
matter	O
on	O
the	O
right	O
frontal	O
lobe,	O
left	O
frontal	O
convexity	O
and	O
right	O
prefrontal	O
region,	O
likely	O
consistent	O
with	O
small	O
thromboembolic	O
ischemic	O
changes.	O
3.	O
There	O
is	O
narrowing	O
of	O
the	O
left	O
internal	O
carotid	O
siphon	O
and	O
distal	O
vascular	O
branches,	O
likely	O
consistent	O
with	O
atherosclerotic	O
disease	O
as	O
described	O
above.	O
4.	O
Mucosal	O
thickening	O
is	O
noted	O
on	O
the	O
left	O
maxillary	O
sinus	O
with	O
air-fluid	O
levels,	O
possibly	O
consistent	O
with	O
ongoing	O
inflammatory	O
process.	O
.	O
Interventional	O
___	O
IMPRESSION:	O
Successful	O
exchange	O
of	O
a	O
temporary	O
hemodialysis	O
catheter	O
for	O
a	O
23	O
cm	O
tunneled	O
hemodialysis	O
catheter.	O
The	O
catheter	O
tip	O
is	O
in	O
the	O
right	O
atrium.	O
The	O
line	O
is	O
ready	O
to	O
use.	O
.	O
CXR	O
___:	O
FINDINGS:	O
In	O
comparison	O
with	O
the	O
study	O
of	O
___,	O
the	O
monitoring	O
and	O
support	O
devices	O
are	O
essentially	O
unchanged.	O
Continued	O
opacification	O
at	O
the	O
left	O
base	O
with	O
blunting	O
of	O
the	O
costophrenic	O
angle,	O
consistent	O
with	O
atelectasis	O
and	O
small	O
effusion.	O
Less	O
prominent	O
changes	O
are	O
seen	O
on	O
the	O
right.	O
.	O
Carotid	O
Ultrasound	O
___	O
Impression:	O
Right	O
ICA	O
70-79%	O
stenosis.	O
Cannot	O
rule	O
out	O
more	O
severe	O
stenosis	O
due	O
to	O
calcification.	O
Consider	O
CTA	O
if	O
clinically	O
indicated.	O
Left	O
ICA	O
no	O
stenosis.	O
On	O
Discharge:	O
140	O
98	O
50	O
----------------<	O
106	O
4.8	O
30	O
4.2	O
Ca:	O
8.8	O
Mg:	O
2.6	O
P:	O
7.4	O
___	O
WBC-17.4	O
Hb-8.7	O
Hct-25.7	O
Plt-540	O
___:	O
26.1	O
PTT:	O
150	O
INR:	O
2.5	O
Brief	O
Hospital	O
Course:	O
Primary	O
Reason	O
for	O
Hospitalization:	O
Mrs.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
with	O
CAD	O
(S/p	O
BMS	O
to	O
mid	O
LAD	O
in	O
___,	O
sCHF	O
(EF	O
40%),	O
PVD	O
s/p	O
R	O
axillobifemoral	O
bypass	O
with	O
graft	O
which	O
the	O
fem-fem	O
is	O
now	O
occluded,	O
carotid	O
endarterectomy	O
x	O
2	O
on	O
the	O
left	O
last	O
in	O
___,	O
s/p	O
SMA	O
PCI,	O
COPD	O
(on	O
2L	O
NC),	O
PEs	O
on	O
coumadin	O
who	O
presents	O
intubated/sedated	O
from	O
OSH	O
in	O
setting	O
of	O
acute	O
pulmonary	O
edema,	O
respiratory	O
failure,	O
oliguric	O
___,	O
and	O
critical	O
left	O
main	O
disease.	O
.	O
Active	O
Diagnoses:	O
#	O
CAD:	O
Cardiac	O
cath	O
showed	O
90%	O
LM,	O
70%	O
RCA	O
lesion,	O
no	O
intervention	O
was	O
performed	O
initially.	O
Initial	O
EKG	O
at	O
OSH	O
showed	O
severe	O
STE	O
in	O
I	O
and	O
aVR,	O
ST	O
depressions	O
in	O
lateral	O
leads.	O
Repeat	O
EKG	O
on	O
transfer	O
looked	O
improved	O
although	O
still	O
with	O
STE	O
in	O
I	O
and	O
aVR.	O
Patient	O
still	O
endorses	O
chest	O
pain	O
when	O
asked.	O
Patient	O
was	O
initially	O
on	O
a	O
heparin	O
gtt	O
and	O
nitro	O
gtt.	O
CT	O
surgery	O
consultation	O
believed	O
patient	O
was	O
too	O
high	O
risk	O
to	O
take	O
for	O
CABG,	O
due	O
to	O
multiple	O
comorbidities.	O
Thus,	O
patient	O
was	O
taken	O
to	O
cardiac	O
cath	O
and	O
DES	O
were	O
placed	O
in	O
left	O
main	O
and	O
RCA.	O
She	O
was	O
continued	O
on	O
coreg	O
3.125	O
mg	O
bid,	O
captopril	O
6.25	O
mg	O
tid,	O
plavix	O
75	O
mg	O
daily,	O
atorvastatin	O
80	O
mg	O
daily,	O
aspirin	O
325	O
mg	O
daily.	O
She	O
is	O
to	O
not	O
stop	O
aspirin	O
or	O
plavix	O
without	O
speaking	O
to	O
her	O
cardiologist.	O
.	O
#	O
Respiratory	O
Distress.	O
Patient	O
was	O
initially	O
intubated	O
at	O
OSH	O
for	O
respiratory	O
distress,	O
thought	O
to	O
be	O
secondary	O
to	O
pneumonia	B-Lower_respiratory_tract_infection
and	O
pulmonary	O
edema.	O
Patient	O
was	O
previously	O
hospitalized	O
a	O
week	O
prior	O
to	O
this	O
current	O
presentation	O
for	O
pneumonia	B-Lower_respiratory_tract_infection
(unclear	O
course),	O
discharged,	O
and	O
repeat	O
CXR	O
on	O
admission	O
looks	O
like	O
worsened	O
pneumonia/CHF.	B-Lower_respiratory_tract_infection
Patient	O
was	O
diuresed	O
at	O
OSH,	O
but	O
developed	O
acute	O
on	O
chronic	O
renal	O
failure.	O
Renal	O
consultation	O
team	O
thought	O
was	O
pre-renal	O
azotemia,	O
so	O
patient	O
was	O
given	O
IVF,	O
and	O
may	O
have	O
redeveloped	O
pulmonary	O
edema.	O
At	O
baseline,	O
patient	O
has	O
severe	O
COPD	O
on	O
2L	O
oxygen	O
at	O
home.	O
She	O
was	O
transferred	O
intubated,	O
sedated	O
on	O
CMV	O
400	O
x	O
14	O
50%	O
FiO2.	O
Fentanyl/versed	O
was	O
used	O
for	O
sedation,	O
as	O
patient	O
is	O
allergic	O
to	O
propofol.	O
CVVH	O
was	O
later	O
initiated	O
for	O
volume	O
management.	O
Patient	O
did	O
well	O
with	O
RISB	O
and	O
SBTs,	O
and	O
was	O
extubated	O
once	O
volume	O
removal	O
was	O
achieved	O
with	O
dialysis.	O
She	O
remains	O
on	O
2L	O
NC	O
on	O
discharge,	O
but	O
oxygenates	O
well	O
on	O
room	O
air	O
to	O
2L	O
NC.	O
.	O
#	O
Altered	B-Delirium
Mental	B-Delirium
Status:	B-Delirium
As	O
sedation	O
was	O
turned	O
off	O
to	O
prepare	O
patient	O
for	O
extubation,	O
it	O
was	O
noted	O
that	O
she	O
had	O
prolonged	O
AMS	B-Delirium
and	O
was	O
not	O
able	O
to	O
follow	O
commands	O
and	O
did	O
not	O
have	O
intact	O
gag	O
reflex.	O
CVVH	O
was	O
continued	O
to	O
correct	O
toxic-metabolic	O
disturbances.	O
CT	O
head	O
was	O
obtained	O
that	O
showed	O
question	O
of	O
ischemic	O
injury	O
in	O
watershed	O
zone	O
between	O
left	O
MCA/PCA	O
territories.	O
A	O
MRI	O
brain	O
was	O
obtained	O
that	O
showed	O
no	O
such	O
infarction,	O
but	O
small	O
areas	O
of	O
acute	O
ischemia	O
in	O
the	O
left	O
frontal	O
lobe.	O
Neurology	O
consult	O
was	O
called,	O
and	O
these	O
areas	O
are	O
believed	O
to	O
be	O
too	O
small	O
to	O
be	O
the	O
cause	O
of	O
AMS.	B-Delirium
Neurology	O
recommended	O
obtaining	O
a	O
carotid	O
duplex	O
for	O
further	O
evaluation	O
of	O
the	O
acute	O
ischemia.	O
Although	O
patient	O
had	O
R	O
ICA	O
stenosis,	O
intervention	O
was	O
felt	O
to	O
be	O
too	O
high	O
risk,	O
and	O
risks	O
would	O
likely	O
outweigh	O
benefits.	O
Her	O
mental	O
status	O
slowly	O
improved	O
and	O
she	O
is	O
near	O
baseline	O
per	O
family	O
on	O
discharge.	O
.	O
#	O
CKD:	O
Patient	O
has	O
solitary	O
kidney,	O
CKD	O
Stage	O
III.	O
On	O
admission	O
to	O
OSH,	O
Cr	O
was	O
1.4,	O
but	O
with	O
diuresis	O
had	O
bumped	O
to	O
4.8.	O
Was	O
initially	O
thought	O
to	O
be	O
pre-renal,	O
but	O
after	O
discontinuing	O
lasix	O
and	O
giving	O
IVF,	O
did	O
not	O
show	O
improvement	O
in	O
renal	O
function,	O
so	O
likely	O
ATN.	O
Was	O
initiated	O
on	O
HD	O
at	O
OSH	O
4	O
days	O
prior	O
to	O
transfer,	O
had	O
received	O
3	O
cycles	O
at	O
OSH.	O
OSH	O
work-up	O
revealed	O
that	O
patient	O
may	O
have	O
renal	O
artery	O
stenosis	O
as	O
evidenced	O
by	O
atrophic	O
kidney	O
(however,	O
this	O
could	O
just	O
be	O
from	O
CKD)and	O
elevated	O
renin	O
and	O
aldosterone.	O
Patient	O
was	O
maintaed	O
on	O
CVVH	O
during	O
this	O
hospitalization.	O
A	O
temporary	O
dialysis	O
catheter	O
was	O
placed,	O
and	O
a	O
tunneled	O
line	O
was	O
then	O
placed.	O
PPD	O
was	O
confirmed	O
negative.	O
She	O
will	O
continue	O
hemodialysis	O
in	O
rehab	O
and	O
outpatient	O
setting.	O
She	O
is	O
discharged	O
on	O
nephrocaps.	O
Epo	O
should	O
be	O
initited	O
with	O
next	O
session	O
of	O
dialysis.	O
Of	O
note,	O
renal	O
recovery	O
is	O
possible	O
for	O
this	O
patient	O
and	O
the	O
need	O
for	O
HD	O
should	O
be	O
continuously	O
reassessed.	O
.	O
#	O
UTI:	B-Urinary_tract_infection
Had	O
enterococcus	O
UTI	B-Urinary_tract_infection
at	O
OSH	O
and	O
received	O
5	O
day	O
course	O
of	O
Unasyn	O
prior	O
to	O
transfer.	O
Upon	O
calling	O
OSH	O
for	O
speciation/sensitivity,	O
it	O
was	O
found	O
that	O
enterococcus	O
only	O
sensitive	O
to	O
vancomycin,	O
so	O
patient	O
has	O
finished	O
a	O
14	O
day	O
course	O
on	O
___.	O
.	O
#	O
Leukocytosis:	O
Patient	O
had	O
leukocytosis	O
at	O
OSH	O
up	O
to	O
30.	O
ID	O
and	O
heme	O
consults	O
both	O
thought	O
could	O
be	O
reactive,	O
secondary	O
to	O
infectious	O
processes	O
(pneumonia,	O
UTI).	B-Urinary_tract_infection
Patient	O
is	O
also	O
noted	O
to	O
have	O
chronic	O
leukocytosis	O
and	O
thrombocytosis,	O
as	O
noted	O
in	O
discharge	O
summary	O
in	O
___.	O
At	O
that	O
time,	O
heme/onc	O
consultation	O
also	O
thought	O
findings	O
were	O
reactive	O
and	O
not	O
associated	O
with	O
hematologic	O
malignancy.	O
Now,	O
WBC	O
37.7	O
with	O
6%	O
bands	O
points	O
to	O
infectious	O
etiology.	O
As	O
patient	O
was	O
treated	O
for	O
infection,	O
leukocytosis	O
trended	O
down	O
to	O
___.	O
BCR-ABL	O
pcr	O
looking	O
for	O
CML	O
was	O
negative.	O
Hematology/oncology	O
team	O
felt	O
that	O
this	O
could	O
be	O
a	O
smoldering	O
myeloproliferative	O
disease	O
with	O
overlying	O
component	O
of	O
infection.	O
JAK	O
2	O
returned	O
positive,	O
and	O
there	O
was	O
a	O
likely	O
presumptive	O
diagnosis	O
of	O
essential	O
thrombocytosis	O
vs	O
other	O
myeloproliferative	O
disorders.	O
.	O
#	O
Thrombocytosis:	O
Patient	O
has	O
thrombocytosis	O
to	O
the	O
millions.	O
Although	O
this	O
could	O
be	O
reactive,	O
should	O
assess	O
other	O
possible	O
sources	O
and	O
hematologic	O
disorder.	O
Jak2	O
mutation	O
looking	O
for	O
myeloproliferative	O
diseases	O
was	O
positive.	O
Platelet	O
count	O
trended	O
down	O
with	O
treatment	O
of	O
infection,	O
indicating	O
a	O
probably	O
reactive	O
etiology	O
as	O
well.	O
Plt	O
count	O
on	O
discharge	O
540k.	O
.	O
#	O
Vasculopathy:	O
Patient	O
is	O
s/p	O
R	O
axillobifemoral	O
bypass	O
with	O
graft	O
which	O
the	O
fem-fem	O
is	O
now	O
occluded,	O
carotid	O
endarterectomy	O
x	O
2	O
on	O
the	O
left	O
last	O
in	O
___,	O
s/p	O
SMA	O
PCI.	O
She	O
has	O
been	O
chronically	O
anticoagulated	O
on	O
coumadin,	O
but	O
coumadin	O
was	O
held	O
for	O
HD	O
line	O
placement	O
at	O
OSH.	O
Patient	O
was	O
later	O
started	O
on	O
plavix	O
and	O
aspirin	O
this	O
admission	O
and	O
maintained	O
on	O
a	O
heparin	O
gtt.	O
Heparin	O
gtt	O
was	O
discontinued	O
when	O
INR	O
was	O
2.5.	O
Goal	O
INR	O
___.	O
.	O
#.	O
Code	O
Status:	O
FULL	O
.	O
Transitional	O
Issues:	O
#	O
Continue	O
HD	O
sessions	O
at	O
rehab	O
and	O
outpatient	O
setting	O
#	O
Speak	O
and	O
Swallow	O
consult	O
#	O
Bladder	O
Scan	O
daily,	O
if	O
>300cc,	O
please	O
straight	O
cath	O
Medications	O
on	O
Admission:	O
Clopidogrel	O
75	O
mg	O
PO	O
daily	O
Tiotropium	O
Bromide	O
18	O
mcg	O
Capsule,1	O
inh	O
daily	O
Fluticasone-Salmeterol	O
250-50	O
mcg/Dose	O
Disk	O
1	O
inh	O
BID	O
Aspirin	O
325	O
mg	O
Tablet	O
PO	O
daily	O
Coumadin	O
3	O
mg	O
PO	O
daily	O
Diltiazem	O
HCl	O
sustained	O
release	O
120	O
mg	O
PO	O
daily	O
Clonidine	O
0.1	O
mg	O
mg	O
PO	O
TID	O
Nitroglycerin	O
0.3	O
mg	O
SL	O
PRN	O
chest	O
pain	O
Metoprolol	O
Tartrate	O
100	O
mg	O
PO	O
BID	O
Simvastatin	O
80mg	O
PO	O
daily	O
Discharge	O
Medications:	O
1.	O
aspirin	O
325	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
atorvastatin	O
80	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
clopidogrel	O
75	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
B	O
complex-vitamin	O
C-folic	O
acid	O
1	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Cap	O
PO	O
DAILY	O
(Daily).	O
5.	O
senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
6.	O
magnesium	O
hydroxide	O
400	O
mg/5	O
mL	O
Suspension	O
Sig:	O
Thirty	O
(30)	O
ML	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
constipation.	B-Constipation
7.	O
carvedilol	O
3.125	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
8.	O
captopril	O
12.5	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day):	O
on	O
days	O
of	O
HD,	O
please	O
give	O
after	O
HD.	O
9.	O
warfarin	O
1	O
mg	O
Tablet	O
Sig:	O
Three	O
(3)	O
Tablet	O
PO	O
Once	O
Daily	O
at	O
4	O
___.	O
10.	O
acetaminophen	O
500	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
11.	O
ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q24H	O
(every	O
24	O
hours):	O
On	O
days	O
of	O
HD,	O
please	O
give	O
after	O
HD.	O
12.	O
albuterol	O
sulfate	O
2.5	O
mg	O
/3	O
mL	O
(0.083	O
%)	O
Solution	O
for	O
Nebulization	O
Sig:	O
One	O
(1)	O
neb	O
Inhalation	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
wheezing.	O
13.	O
ipratropium	O
bromide	O
0.02	O
%	O
Solution	O
Sig:	O
One	O
(1)	O
neb	O
Inhalation	O
Q6H	O
(every	O
6	O
hours).	O
14.	O
isosorbide	O
mononitrate	O
30	O
mg	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
15.	O
docusate	O
sodium	O
100	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day.	O
16.	O
citalopram	O
20	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
17.	O
nitroglycerin	O
0.3	O
mg	O
Tablet,	O
Sublingual	O
Sig:	O
One	O
(1)	O
Tablet,	O
Sublingual	O
Sublingual	O
PRN	O
(as	O
needed)	O
as	O
needed	O
for	O
Chest	O
pain.	O
18.	O
Epogen	O
Injection	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
PRIMARY:	O
1.	O
Acute	O
coronary	O
syndrome	O
2.	O
End	O
stage	O
renal	O
disease,	O
on	O
hemodialysis	O
3.	O
Essential	O
thrombocytosis	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
.	O
You	O
were	O
transferred	O
to	O
our	O
cardiology	O
ICU	O
as	O
you	O
were	O
having	O
a	O
heart	O
attack.	O
While	O
here,	O
you	O
had	O
a	O
stent	O
placed	O
in	O
your	O
left	O
main	O
coronary	O
artery	O
and	O
right	O
coronary	O
artery	O
on	O
RCA	O
___.	O
There	O
were	O
no	O
complications.	O
You	O
were	O
on	O
a	O
beathing	O
machine	O
and	O
mechanical	O
ventilator,	O
which	O
you	O
recovered	O
from.	O
.	O
You	O
required	O
dialysis	O
during	O
your	O
inpatient	O
stay,	O
and	O
will	O
need	O
dialysis	O
on	O
discharge.	O
You	O
will	O
be	O
set	O
up	O
with	O
a	O
kidney	O
doctor	O
and	O
appointment	O
on	O
discharge.	O
Please	O
have	O
your	O
kidney	O
doctor	O
start	O
___	O
with	O
hemodialysis	O
.	O
You	O
were	O
noted	O
to	O
have	O
a	O
complicated	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
You	O
are	O
receiving	O
vancomycin	O
therapy,	O
which	O
will	O
be	O
dosed	O
per	O
dialysis	O
protocol.	O
You	O
have	O
completed	O
the	O
entire	O
course	O
of	O
antibiotics	O
for	O
this	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
.	O
You	O
were	O
also	O
noted	O
to	O
have	O
high	O
white	O
blood	O
cell	O
count	O
and	O
high	O
platelet	O
count,	O
which	O
is	O
concerning	O
for	O
a	O
myeloproliferative	O
disorder.	O
You	O
also	O
had	O
a	O
test	O
that	O
was	O
positive	O
for	O
a	O
JAK2	O
mutation,	O
which	O
is	O
often	O
found	O
in	O
myeloproliferative	O
disorders.	O
You	O
will	O
have	O
follow-up	O
for	O
this	O
condition	O
in	O
___	O
clinic.	O
.	O
You	O
had	O
several	O
medication	O
changes	O
while	O
here	O
in	O
the	O
hospital.	O
Please	O
take	O
your	O
medications	O
as	O
prescribed	O
below.	O
Acetaminophen	O
1000	O
mg	O
PO/NG	O
TID	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H:PRN	O
wheezing	O
Aspirin	O
325	O
mg	O
PO/NG	O
DAILY	O
Atorvastatin	O
80	O
mg	O
PO/NG	O
DAILY	O
Clopidogrel	O
75	O
mg	O
PO/NG	O
DAILY	O
Captopril	O
6.25	O
mg	O
PO/NG	O
TID	O
Carvedilol	O
3.125	O
mg	O
PO/NG	O
BID	O
Citalopram	O
10	O
mg	O
PO/NG	O
DAILY	O
Docusate	O
Sodium	O
100	O
mg	O
PO/NG	O
BID	O
Ipratropium	O
Bromide	O
Neb	O
1	O
NEB	O
IH	O
Q6H	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
Milk	O
of	O
Magnesia	O
30	O
mL	O
PO/NG	O
Q6H:PRN	O
constipation	B-Constipation
Nephrocaps	O
1	O
CAP	O
PO	O
DAILY	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
PRN	O
Chest	O
pain	O
Ranitidine	O
150	O
mg	O
PO/NG	O
Q24H	O
Senna	O
1	O
TAB	O
PO/NG	O
BID	O
Warfarin	O
3	O
mg	O
PO/NG	O
DAILY	O
Start	O
Epogen	O
as	O
prescribed	O
by	O
your	O
kidney	O
doctor.	O
.	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
Followup	O
Instructions:	O
___	O

